Search Results - "Lopez‐Lorenzo, Jose‐Luis"
-
1
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia
Published in British journal of haematology (01-06-2023)Get full text
Journal Article -
2
Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain
Published in Leukemia research (01-06-2012)“…Abstract Bendamustine is a alkylating agent with a purine-like benzamidazole ring currently approved in Europe for indolent non-Hodgkin lymphoma (NHL), chronic…”
Get full text
Journal Article -
3
Busulfan and subsequent malignancy: An evidence‐based risk assessment
Published in Pediatric blood & cancer (01-01-2024)“…Background The incidence of secondary malignancies associated with busulfan exposure is considered low, but has been poorly characterized. Because this…”
Get full text
Journal Article -
4
-
5
Primary Effusion Lymphoma, Multicentric Castleman's Disease, and Kaposi's Sarcoma in an HHV-8 and HIV-Positive Patient: A Case Report
Published in Medicina (Kaunas, Lithuania) (01-05-2023)“…Primary effusion lymphoma (PEL), Kaposi's sarcoma (KS), and multicentric Castleman's disease (MCD) is an uncommon group of diseases included in the same…”
Get full text
Journal Article -
6
Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain
Published in Clinical lymphoma, myeloma and leukemia (01-10-2021)“…•Bimodal wave of COVID-19 infection occurs in many European countries, including Spain.•Adults with acute lymphoblastic leukemia (ALL) had similar poor outcome…”
Get full text
Journal Article -
7
Acute leukemia arising from myeloproliferative or myelodysplastic/myeloproliferative neoplasms: A series of 372 patients from the PETHEMA AML registry
Published in Leukemia research (01-04-2022)“…Treatment of acute myeloid leukemia (AML) evolving from myeloproliferative (MPN) or myelodysplastic/myeloproliferative neoplasms (MDS/MPN) is challenging. We…”
Get full text
Journal Article -
8
Invasive Cutaneous Candidiasis, Autoimmune Hemolytic Anemia and Pancytopenia: A Challenging Scenario for Waldenström Macroglobulinemia in an Elderly Patient
Published in Biomedicines (24-03-2023)“…Waldenström macroglobulinemia (WM) is a slowly progressive hematologic malignancy that usually responds rapidly to treatment. Being a lymphoplasmacytoid…”
Get full text
Journal Article -
9
Comparison of Droplet Digital PCR versus qPCR Measurements on the International Scale for the Molecular Monitoring of Chronic Myeloid Leukemia Patients
Published in Molecular diagnosis & therapy (01-10-2020)“…Background BCR - ABL1/ABL1 p210 measurement by quantitative polymerase chain reaction (qPCR) is used worldwide to monitor the molecular response in chronic…”
Get full text
Journal Article -
10
Uveitis and Myositis as Immune Complications in Chemorefractory NK/T-Cell Nasal-Type Lymphoma Successfully Treated with Allogeneic Stem-Cell Transplant
Published in Case reports in hematology (01-01-2016)“…NK/T-cell lymphomas are a group of clonal proliferations of NK- or, rarely, T-cell types and have peculiar clinicopathologic features. Most common site of…”
Get full text
Journal Article -
11
-
12
The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial
Published in Cancers (18-05-2021)“…We sought to predict treatment responses and outcomes in older patients with newly diagnosed acute myeloid leukemia (AML) from our FLUGAZA phase III clinical…”
Get full text
Journal Article -
13
Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant
Published in Frontiers in immunology (19-05-2021)“…BackgroundDonor specific antibodies (DSAs) can be responsible for graft failure (GF) in the setting of mismatched hematopoietic stem cell transplantation…”
Get full text
Journal Article -
14
Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study
Published in Leukemia research (01-05-2020)“…•Elderly acute myeloblastic leukaemia patients on intensive chemotherapy included.•The Acute Leukaemia French Association model’s ‘benefit’ group had longer…”
Get full text
Journal Article -
15
An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase
Published in Journal of cancer research and clinical oncology (01-10-2017)“…Purpose This study was aimed to analyze the association of very early molecular response to nilotinib with the achievement of deep molecular response (MR4) at…”
Get full text
Journal Article -
16
RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas
Published in BMC cancer (16-04-2018)“…Precursor T-cell lymphoblastic lymphomas (T-LBL) are rare aggressive hematological malignancies that mainly develop in children. As in other cancers, the loss…”
Get full text
Journal Article -
17
ZBTB16-RARα-Positive Atypical Promyelocytic Leukemia: A Case Report
Published in Medicina (Kaunas, Lithuania) (06-04-2022)“…The majority of patients with acute promyelocytic leukemia (APL) manifest a specific chromosomal translocation t(15;17)(q22;q21), characterized by the fusion…”
Get full text
Journal Article -
18
The FLT3-like Gene Expression Signature Predicts Response to Quizartinib in Wild-Type FLT3 Acute Myeloid Leukemia: An Analysis of the Pethema Quiwi Trial
Published in Blood (02-11-2023)“…Background The identification of predictive biomarkers is crucial for guiding treatment decisions in acute myeloid leukemia (AML). Previously, we identified a…”
Get full text
Journal Article -
19
Treatment Outcomes in Unfit Patients with Newly Acute Myeloid Leukemia According to IDH1 Mutational Status: Real World Evidence from the Pethema Epidemiologic Registry
Published in Blood (02-11-2023)“…Background: Current treatment of unfit acute myeloid leukemia (AML) patients include hypomethylating agents (HMA) with or without venetoclax, low-dose…”
Get full text
Journal Article -
20
Exploring Potential Molecular Mechanisms of Drug Response in FLT3-ITD Negative AML Patients Treated with Quizartinib Vs Placebo Plus Standard Chemotherapy in the Quiwi Trial
Published in Blood (02-11-2023)“…Introduction Wild-type FLT3 AML presents significant therapeutic challenges due to limited treatment options. The QUIWI trial investigated quizartinib (Quiz)…”
Get full text
Journal Article